NCT03479190View on ClinicalTrials.gov

Platelet Rich Plasma Versus Placebo for the Treatment of Greater Trochanteric Pain Syndrome (HiPPO Trial)

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 3, 2018

Primary Completion Date

February 28, 2022

Study Completion Date

April 3, 2022

Conditions

Greater Trochanteric Pain Syndrome

Interventions

PROCEDURE

ultrasound guided injection of Platelet rich plasma

Platelet rich plasma (PRP) injection into trochanteric area under ultrasound guidance

PROCEDURE

ultrasound guided injection of Normal Saline

ultrasound guided injection of Normal Salineinto trochanteric area under ultrasound guidance

Trial Locations (1)

Unknown

Northumbria Healthcare NHS Trust, Newcastle upon Tyne

All Listed Sponsors

lead

Northumbria Healthcare NHS Foundation Trust

OTHER

NCT03479190 - Platelet Rich Plasma Versus Placebo for the Treatment of Greater Trochanteric Pain Syndrome (HiPPO Trial) | Biotech Hunter | Biotech Hunter